Can-Ming Chen

Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor–positive Breast Cancer

Sheng Chen, Can-Ming Chen, Ke‐Da Yu et al. · Annals of Surgical Oncology · 2012 · 60 citations

Medicine, Oncology, Breast Oncology +14

Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis

Ruo-Xi Wang, Sheng Chen, Xi Jin et al. · Breast Cancer Research and Treatment · 2016 · 47 citations

Medicine, Oncology, Pharmacology +17

Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge

Guang‐Yu Liu, Jing-Song Lu, Kun-Wei Shen et al. · Breast Cancer Research and Treatment · 2007 · 38 citations

Medicine, Diagnostic Sciences, Pathology +7

Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy

Sheng Chen, Liang Huang, Can-Ming Chen et al. · Oncotarget · 2015 · 36 citations · Full text

Medicine, Endocrinology, Oncology +16

Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months

Ou Huang, Can-Ming Chen, JiaYi Wu et al. · BMC Cancer · 2009 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17